Browsing Tag
Pulmonary Fibrosis
2 posts
Can LTI-03 break through in a crowded idiopathic pulmonary fibrosis market
Rein Therapeutics advances LTI-03 in Phase 2 IPF trials. Find out what this means for competition, execution risk, and future differentiation.
Cyclopharm secures major US Department of Defense contract for Technegas supply
Cyclopharm Limited, the Australian-based radiopharmaceutical company, has taken a significant step in its US expansion efforts by signing…